Michael H.
- Country
- Germany
- Department
- München Klinik Neuperlach Klinik für Hämatologie und Onkologie
Research Overview
- Phase II Trial Comparing Trifluridine/Tipiracil with Panitumumab Versus Trifluridine/Tipiracil with Bevacizumab in Metastatic Colorectal Cancer
- Efficacy of Post-Resection Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin in Metastatic Colorectal Cancer: A Phase III Randomized Trial
- Comparison of Ramucirumab with Irinotecan, Leucovorin, and 5-FU Versus Ramucirumab with Paclitaxel in Advanced or Metastatic Gastric Adenocarcinoma
Data & Insights
Has run more than one trial at 32 of 123 partner sites.
Specializations
Colorectal Cancer Research
The investigator specializes in the treatment of metastatic colorectal cancer, with particular focus on developing innovative therapeutic strategies for patients following surgical interventions.
- Post-resection treatment optimization
- Post-ablation therapeutic approaches
- First-line treatment strategies
Their research explores various therapeutic combinations including targeted biological agents for metastatic disease management.
Gastrointestinal Oncology
The investigator conducts advanced research in gastroesophageal cancer treatment, particularly focusing on therapeutic approaches for adenocarcinoma.
- Advanced gastric cancer management
- Gastroesophageal junction tumors
- Second-line treatment strategies
Their work includes investigating combination therapies with targeted biological agents and conventional chemotherapy regimens.
Treatment Innovation
The investigator focuses on developing novel therapeutic combinations for gastrointestinal cancers, with emphasis on improving patient outcomes.
- Combination therapy approaches
- Treatment sequencing strategies
- Advanced disease management
Their research encompasses both early-line and subsequent treatment options for patients with advanced gastrointestinal malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.